Pharma & Biotech

Recent SEC filings have revealed a significant development for biotechnology firm Design Therapeutics: investment management company Acadian Asset Management now...

Iovance Biotherapeutics is confronting a severe equity downturn, with its stock value declining by 69% since the start of the...

Rallybio's stock continues to exhibit significant price swings despite recent gains, with technical indicators and trading patterns presenting a complex...

The biotechnology firm Ardelyx approaches a definitive moment in its corporate history. A court ruling scheduled for September 25th will...

French biotechnology firm Valneva has encountered a severe regulatory obstacle following the US Food and Drug Administration's (FDA) immediate suspension...

CSL Limited's stock is experiencing a historic downturn, reaching its lowest price point in five years. The biotechnology giant is...

Nuvation Bio's stock is demonstrating extreme volatility, creating a sharp division within the investment community. While some traders focus on...

Zentalis Pharmaceuticals LLC is navigating a complex turnaround. The biotech firm has announced a significant addition to its executive team...

While Nautilus Biotechnology's stock has faced substantial selling pressure for months, a significant development has emerged from the executive suite....

A notable divergence has emerged at Recursion Pharmaceuticals between the actions of corporate insiders and the outlook of Wall Street...